{
  "trial_id": "NCT01257880",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age 18-55 years",
      "label": "met"
    },
    {
      "criterion": "Ability to speak, read, and understand English",
      "label": "met"
    },
    {
      "criterion": "Documented diagnosis of migraine aura (MA) for a \u22652 year period preceding enrollment",
      "label": "unknown"
    },
    {
      "criterion": "Average of 4 to 14 migraine days per month for the 3-month period preceding enrollment",
      "label": "met"
    },
    {
      "criterion": "Migraine prevention regimen stable for at least 30 days prior to enrollment",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnancy",
      "label": "not_met"
    },
    {
      "criterion": "Postmenopausal female",
      "label": "not_met"
    },
    {
      "criterion": "Documented right-to-left shunt (RLS) with 11 to 100 ET at rest or following calibrated or uncalibrated respiratory strain by TCD",
      "label": "unknown"
    }
  ],
  "notes": "62-year-old African-American man presented with left upper and lower extremity weakness, associated with dark visual spot in right eye, right facial numbness, facial drop and slurred speech.",
  "_meta": {
    "topic_id": "47",
    "trial_id": "NCT01257880",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}